The serum levels of the cytokines involved in the Th17 and Th1 cell commitment are increased in individuals with borderline thrombocytopenia

Journal of Hematology and Oncology

Volumn 6, Issue 1, 2013, Pages

  Rocha, Andreia Maria Camargos ^a   Souza, Cláudia ^a   Rocha, Gifone Aguiar ^a   De Melo, Fabrício Freire ^a   Clementino, Nelma Cristina Diogo ^a   Marino, Marília Campos Abreu ^a   Queiroz, Dulciene Maria Magalhães ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

IL1RN VNTR; IL2 330; Th1 and Th17 cytokines; Thrombocytopenia

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; BLOOD LEVEL; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; TH1 CELL; TH17 CELL;

ADULT; AGED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-17; MALE; MIDDLE AGED; PROGNOSIS; TH1 CELLS; TH17 CELLS; THROMBOCYTOPENIA; YOUNG ADULT;

EID: 84876941732     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-6-28     Document Type: Article

References (7)

1. International consensus report on the investigation and management of primary immune thrombocytopenia. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter D, Blood 2010 115 168 186 10.1182/blood-2009-06-225565 19846889
2. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report form an international working group. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kühne T, Ruggeri M, George JN, Blood 2009 113 2386 2393 10.1182/blood-2008-07-162503 19005182
3. Long-term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopenia. Stasi R, Amadori S, Osborn J, Newland AC, Provan D, Plos Medicine 2006 3 388 394
4. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA, Blood 2011 117 4190 4207 10.1182/blood-2010-08-302984 21325604
5. Applicability of 2009 international consensus terminology and criteria for immune thrombocytopenia to a clinical pediatric population. Grace RF, Long M, Kalish LA, Neufeld EJ, Pediatr Blood Cancer 2012 58 216 220 10.1002/pbc.23112 21674757
6. The levels of IL-17A and of the cytokines involved in the Th17 cell commitment are increased in patients with chronic Immune Thrombocytopenia. Rocha AMC, Souza C, Rocha GA, Melo FF, Clementino NCD, Marino MCA, Bozzi A, Silva ML, Martins-Filho OA, Queiroz DMM, Haematologica 2011 96 1560 1564 10.3324/haematol.2011.046417 21972211
7. IL1RN VNTR and IL2-330 polymorphic genes are independently associated with chronic immune thrombocytopenia. Rocha AMC, Souza C, Rocha GA, Melo FF, Saraiva ISB, Clementino NCD, Marino MCA, Queiroz DMM, Br J Haematol 2010 150 679 684 10.1111/j.1365-2141.2010.08318.x 20626741